Identification of ortho-hydroxy anilide as a novel scaffold for lysine demethylase 5 inhibitors

被引：6

作者：

Jaikhan, Pattaporn ^{[1
]}

Buranrat, Benjaporn ^{[1
,2
]}

Itoh, Yukihiro ^{[1
]}

Chotitumnavee, Jiranan ^{[1
]}

Kurohara, Takashi ^{[1
]}

Suzuki, Takayoshi ^{[1
,3
]}

机构：

[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Sakyo Ku, 1-5 Shimogamohangi Cho, Kyoto 6060823, Japan

[2] Mahasarakham Univ, Fac Med, Biomed Sci Res Unit, Muang Dist 44000, Maha Sarakham, Thailand

[3] Japan Sci & Technol Agcy JST, CREST, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2019年 / 29卷 / 10期

关键词：

Small molecule; Drug design; Histone deacetylase; Lysine demethylase; Inhibitor; HISTONE DEMETHYLASES; CANCER; DOMAIN; METHYLATION; MECHANISMS;

D O I：

10.1016/j.bmcl.2019.03.028

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Fe(II)/alpha-ketoglutarate-dependent lysine demethylases (KDMs) are attractive drug targets for several diseases including cancer. In this study, we designed and screened ortho-substituted anilides that are expected to function as Fe(II) chelators, and identified ortho-hydroxy anilide as a novel scaffold for KDM5A inhibitors. Treatment of human lung cancer A549 cells with a prodrug form of 4-carboxy-2-hydroxy-formanilide (9c) increased trimethylated lysine 4 on histone H3 level, suggesting KDM5 inhibition in the cells.

引用

页码：1173 / 1176

页数：4

共 50 条

[1] Identification of novel lysine demethylase 5-selective inhibitors by inhibitorbased fragment merging strategy
Miyake, Yuka
Itoh, Yukihiro
Hatanaka, Atsushi
Suzuma, Yoshinori
Suzuki, Miki
Kodama, Hidehiko
Arai, Yoshinobu
Suzuki, Takayoshi
BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (06) : 1119 - 1129
[2] Identification of catechols as histone-lysine demethylase inhibitors
Nielsen, Anders L.
Kristensen, Line H.
Stephansen, Karen B.
Kristensen, Jan B. L.
Helgstrand, Charlotte
Lees, Michael
Cloos, Paul
Helin, Kristian
Gajhede, Michael
Olsen, Lars
FEBS LETTERS, 2012, 586 (08) : 1190 - 1194
[3] Characterization of KDM5 lysine demethylase family substrate preference and identification of novel substrates
Hoekstra, Matthew
Ridgeway, Nashira H.
Biggar, Kyle K.
JOURNAL OF BIOCHEMISTRY, 2022, 173 (01): : 31 - 42
[4] Novel inhibitors of lysine (K)-specific Demethylase 4A with anticancer activity
Lee, Hyo Jeong
Kim, Bo-Kyoung
Yoon, Kyoung Bin
Kim, Yong-Chul
Han, Sun-Young
INVESTIGATIONAL NEW DRUGS, 2017, 35 (06) : 733 - 741
[5] Novel inhibitors of lysine (K)-specific Demethylase 4A with anticancer activity
Hyo Jeong Lee
Bo-Kyoung Kim
Kyoung Bin Yoon
Yong-Chul Kim
Sun-Young Han
Investigational New Drugs, 2017, 35 : 733 - 741
[6] Novel inhibitors of lysine (K)-specific demethylase 4A with anticancer activity
Lee, H. J.
Han, S.
FEBS OPEN BIO, 2018, 8 : 305 - 305
[7] Identification of Cell-Active Lysine Specific Demethylase 1-Selective Inhibitors
Ueda, Rie
Suzuki, Takayoshi
Mino, Koshiki
Tsumoto, Hiroki
Nakagawa, Hidehiko
Hasegawa, Makoto
Sasaki, Ryuzo
Mizukami, Tamio
Miyata, Naoki
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2009, 131 (48) : 17536 - 17537
[8] In silico design of novel and highly selective lysine-specific histone demethylase inhibitors
Akdogan, Ebru Demet
Erman, Burak
Yelekci, Kemal
TURKISH JOURNAL OF CHEMISTRY, 2011, 35 (04) : 523 - 542
[9] Synthesis and Evaluation of Novel Cyclic Peptide Inhibitors of Lysine-Specific Demethylase 1
Kumarasinghe, Isuru R.
Woster, Patrick M.
ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (01): : 29 - 33
[10] Development of 5-hydroxypyrazole derivatives as reversible inhibitors of lysine specific demethylase 1
Mould, Daniel P.
Bremberg, Ulf
Jordan, Allan M.
Geitmann, Matthis
Maiques-Diaz, Alba
McGonagle, Alison E.
Small, Helen F.
Somervaille, Tim C. P.
Ogilvie, Donald
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (14) : 3190 - 3195

← 1 2 3 4 5 →